Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Liability and Pharmacology of Mephedrone
NCT02232789Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of mephedrone (3 arms), sponsored by Parc de Salut Mar. Primary endpoint: Changes in blood pressure at 4 hours. Started Sep 2014; status: completed.
02
Drugs
mephedrone
Beyond the preview
Go deeper on NCT02232789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232789.